Skip to main content

Spirulina ingestion and autoimmune disease onset or flare

Dear Editor,

Spirulina is widely utilized as a feed additive in agriculture and as a nutritional supplement for human consumption, owing to its rich concentration of proteins, vitamins, and minerals. Research suggests that Spirulina may have immunomodulatory effects. For instance, in vitro studies conducted on cat macrophages have shown that Spirulina can enhance phagocytic activity against Escherichia coli and sheep red blood cells, with minimal cytotoxic effects [1]. Moreover, an in vivo study involving chicks fed with Spirulina-enriched feed demonstrated an increase in the number of macrophages, leading to enhanced phagocytic activity and increased nitrite production in response to both lipopolysaccharide (LPS) and non-LPS stimuli [2]. Additionally, a study on humans revealed that oral administration of a hot water extract of Spirulina improved natural killer (NK) cell function, as evidenced by increased interferon production and cytolysis [3]. However, there is also concern regarding the potential of Spirulina to trigger autoimmune diseases. This review aims to examine the relationship between Spirulina ingestion and autoimmune diseases onset or flare. The literature on this field was screened until July 2024. No language restrictions were applied. Pubmed, Scopus, and Web of Science were the database analyzed.

The search found four articles with five cases reported [4,5,6,7]. The age varied from 45 to 82 years old, and 4/5 were female gender. Spirulina started dermatomyositis in 3/5 cases [4, 5, 7] and pemphigus in 2/5 [6, 7]. The time between spirulina ingestion and autoimmune onset varied from 1 to 2 days to 1 year. All patients with dermatomyositis had skin lesions compatible with this disease and proximal muscle weakness. The skin biopsy showed interface dermatitis in all cases. All these cases had high levels of creatine kinase, and aldolase was high in 2/3 cases (in the third case, this enzyme was not described). Creatine kinase values varied from 1268 to 4761 U/L and aldolase from 22.6 to 31.1 U/L. One patient had interstitial lung diseases and positive anti-Mi-1 antibodies [4]. One of the pemphigus cases developed a mixture of pemphigus foliaceous and bullous pemphigoid [7]; the other patient had a flare of previous pemphigus [6].

All patients had Spirulina suspended, and all cases received prednisone. Methylprednisolone was done in 2/5 cases (all dermatomyositis) [4, 5], intravenous immunoglobulin in 1/5 case [4], and cyclophosphamide in 1/5 [5]. One patient received hydroxychloroquine, topical tacrolimus, and cetirizine [7]. In 3/5 cases, the diseases improved or were cured after spirulina withdrawal and/or immunosuppressive drugs [4,5,6]. In 2/5, the outcome was not described in the article [7]. See Table 1 for a summary of all patient data.

Table 1 Studies on spirulin ingestion and autoimmune disease onset or flare

No article on positive effects of spirulina in autoimmune diseases was found.

It has been suggested that the immunostimulatory properties of Spirulina may lead to aberrant immune responses and subsequent autoimmunity [8]. In addition, chicks fed a Spirulina-supplemented diet exhibited a significant increase in macrophage numbers, along with an overall enhancement in phagocytic activity and nitrite production, both in LPS-induced and non-LPS-induced conditions [2]. Additionally, a human study demonstrated that oral administration of a extract of Spirulina enhanced NK cell function, as evidenced by increased interferon-γ production and cytolytic activity [3].

Future case reports on Spirulina and autoimmune disease onset or flare are awaited since this herbal supplement is consumed worldwide.

This review showed that spirulina ingestion may be correlated with dermatomyositis and pemphigus development/flare. Patients with autoimmune disease should be alert for flares after this herbal supplement ingestion. We concluded that Spirulina should be used with caution in patients with autoimmune diseases, especially dermatomyositis and pemphigus. Subjects using Spirulina should be monitored to the appearance of autoimmune conditions. Future studies on spirulina ingestion and its complications in autoimmune disorders are indeed needed.

Data availability

No datasets were generated or analysed during the current study.

References

  1. Qureshi MA, Ali RA. Spirulina platensis exposure enhances macrophage phagocytic function in cats. Immunopharmacol Immunotoxicol. 1996;18(3):457–63.

    Article  CAS  PubMed  Google Scholar 

  2. Al-Batshan HA, Al-Mufarrej SI, Al-Homaidan AA, Qureshi MA. Enhancement of chicken macrophage function and nitrite production by dietary spirulina platensis. Immunopharmacol Immunotoxicol. 2001;23(2):281–9.

    Article  CAS  PubMed  Google Scholar 

  3. Hirahashi T, Matsumoto M, Hazeki K, Saeki Y, Ui M, Seya T. Activation of the human innate immune system by spirulina: augmentation of interferon production and NK cytotoxicity by oral administration of hot water extract of spirulina platensis. Int Immunopharmacol. 2002;2(4):423–34.

    Article  CAS  PubMed  Google Scholar 

  4. Kuzumi A, Yoshizaki A, Kawanabe R, Sato S. Anti-Mi-2 antibody-positive dermatomyositis following spirulina intake. Rheumatology (Oxford). 2024;63(9):e264–5.

    Article  PubMed  Google Scholar 

  5. Konno T, Umeda Y, Umeda M, Kawachi I, Oyake M, Fujita N. A case of inflammatory myopathy with widely skin rash following use of supplements containing spirulina. Rinsho Shinkeigaku. 2011;51(5):330–3.

    Article  PubMed  Google Scholar 

  6. Kraigher O, Wohl Y, Gat A, Brenner S. A mixed immunoblistering disorder exhibiting features of bullous pemphigoid and pemphigus foliaceus associated with spirulina algae intake. Int J Dermatol. 2008;47(1):61–3.

    Article  PubMed  Google Scholar 

  7. Lee AN, Werth VP. Activation of autoimmunity following use of immunostimulatory herbal supplements. Arch Dermatol. 2004;140(6):723–7.

    Article  PubMed  Google Scholar 

  8. Bax CE, Chakka S, Concha JSS, Zeidi M, Werth VP. The effects of immunostimulatory herbal supplements on autoimmune skin diseases. J Am Acad Dermatol. 2021;84:1051–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

None.

Funding

None.

Author information

Authors and Affiliations

Authors

Contributions

J.F.C. performed the data analysis, wrote and submitted the article. A.T.A.M.: performed the revision, and wrote the manuscript.

Corresponding author

Correspondence to Jozélio Freire de Carvalho.

Ethics declarations

Ethical approval

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

de Carvalho, J.F., Martinez, A.T.A. Spirulina ingestion and autoimmune disease onset or flare. Adv Rheumatol 65, 15 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s42358-025-00446-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s42358-025-00446-7

Keywords